Isam Vaid1, Kaha Ahmed, Dianne May, Diane Manheim. 1. WISEWOMAN Program, Division of Heart Disease and Stroke Prevention, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention , Atlanta, Georgia . *
Abstract
BACKGROUND: Tobacco use is a major risk factor for cardiovascular disease (CVD) and is the leading preventable cause of death, disease, and disability in the United States. The CDC's Well-Integrated Screening and Evaluation for Women Across the Nation (WISEWOMAN) program addresses the heart health of low-income under- or uninsured women between the ages of 40 and 64 years. This article discusses WISEWOMAN's key approaches to smoking cessation and their impact on WISEWOMAN participants' cardiovascular health. METHODS: A longitudinal retrospective analysis was conducted using data from 21 funded CDC programs from July 2008 to June 2013. Data were collected on 149,767 women to assess CVD risk, smoking status, and utilization of programs related to tobacco cessation. RESULTS: The overall prevalence of smoking among the WISEWOMAN population during this period was 28%. Increases in referrals to tobacco quitlines, tobacco-cessation counseling, lifestyle interventions, and other community-based tobacco-cessation programs contributed to a 15% smoking-cessation rate among smokers who returned for a rescreening assessment over the 5-year program period. CONCLUSION: The WISEWOMAN program has observed a smoking-cessation rate of 15% over the 5-year program period. WISEWOMAN's key approaches include continuous technical assistance that highlights quitline referrals, motivational interviewing done by program staff, and professional-development strategies for WISEWOMAN healthcare providers. WISEWOMAN will continue its programmatic emphasis on smoking cessation by partnering with state tobacco-cessation programs to work toward a lower smoking-prevalence rate among program participants.
BACKGROUND:Tobacco use is a major risk factor for cardiovascular disease (CVD) and is the leading preventable cause of death, disease, and disability in the United States. The CDC's Well-Integrated Screening and Evaluation for Women Across the Nation (WISEWOMAN) program addresses the heart health of low-income under- or uninsured women between the ages of 40 and 64 years. This article discusses WISEWOMAN's key approaches to smoking cessation and their impact on WISEWOMAN participants' cardiovascular health. METHODS: A longitudinal retrospective analysis was conducted using data from 21 funded CDC programs from July 2008 to June 2013. Data were collected on 149,767 women to assess CVD risk, smoking status, and utilization of programs related to tobacco cessation. RESULTS: The overall prevalence of smoking among the WISEWOMAN population during this period was 28%. Increases in referrals to tobacco quitlines, tobacco-cessation counseling, lifestyle interventions, and other community-based tobacco-cessation programs contributed to a 15% smoking-cessation rate among smokers who returned for a rescreening assessment over the 5-year program period. CONCLUSION: The WISEWOMAN program has observed a smoking-cessation rate of 15% over the 5-year program period. WISEWOMAN's key approaches include continuous technical assistance that highlights quitline referrals, motivational interviewing done by program staff, and professional-development strategies for WISEWOMAN healthcare providers. WISEWOMAN will continue its programmatic emphasis on smoking cessation by partnering with state tobacco-cessation programs to work toward a lower smoking-prevalence rate among program participants.
Authors: Lee R Mobley; Elisabeth D Root; Eric A Finkelstein; Olga Khavjou; Rosanne P Farris; Julie C Will Journal: Am J Prev Med Date: 2006-04 Impact factor: 5.043
Authors: Paula A Keller; Annamaria Feltracco; Linda A Bailey; Zhanhai Li; Jeff Niederdeppe; Timothy B Baker; Michael C Fiore Journal: Prev Chronic Dis Date: 2010-02-15 Impact factor: 2.830
Authors: Jennifer Irvin Vidrine; Sanjay Shete; Yumei Cao; Anthony Greisinger; Penny Harmonson; Barry Sharp; Lyndsay Miles; Susan M Zbikowski; David W Wetter Journal: JAMA Intern Med Date: 2013-03-25 Impact factor: 21.873
Authors: Cheryl L Robbins; Thomas C Keyserling; Stephanie Jilcott Pitts; John Morrow; Merry-K Moos; Larry F Johnston; Sherry L Farr Journal: J Womens Health (Larchmt) Date: 2014-12-17 Impact factor: 2.681